NYXH Nyxoah

Publication relating to transparency notification

Publication relating to transparency notification

REGULATED INFORMATION

Publication relating to transparency notification

Mont-Saint-Guibert (Belgium), January 12, 2026, 7:00 am CET / 1:00 am ET In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.

BNP Paribas Asset Management

On January 8, 2026, Nyxoah received a transparency notification from BNP Paribas Asset Management SA. Based on the notification, BNP Paribas Asset Management Europe SAS holds 1,409,791 voting rights, representing 3.28% of the total number of voting rights on December 31, 2025 (43,026,460).

The notification dated January 7, 2026 contains the following information:

  • Reason for the notification: acquisition or disposal of voting securities or voting rights
  • Notification by: a parent undertaking or a controlling person
  • Person subject to the notification requirement: BNP Paribas Asset Management SA (with address at SA 47000-75318 Paris cedex 09-France)
  • Date on which the threshold was crossed: December 31, 2025
  • Threshold that is crossed: 3%
  • Denominator: 43,026,460
  • Notified details:



A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
BNP Paribas Asset Management Holding00 0.00% 
BNP Paribas Asset Management Europe SAS696,5621,409,791 3.28% 
Subtotal696,5621,409,791 3.28% 
 TOTAL1,409,79103.28%0.00%
  • Full chain of controlled undertakings through which the holding is effectively held: The subsidiary BNP Paribas Asset Management Europe SAS is controlled by the parent company BNP Paribas Asset Management Holding. This parent company is itself controlled by the parent company BNP Paribas SA, which benefits from an exemption from aggregating its shareholdings with those of its subsidiaries investment companies, in accordance with article 21, paragraph 2 of the Royal Decree of February 14, 2008 on the disclosure of major shareholdings.
    • Additional information: The subsidiary BNP Paribas Asset Management Europe SAS is an investment company that exercises voting rights on a discretionary basis in the absence of specific instructions. Following the merger between BNP Paribas Asset Management Europe SAS and AXA Investment Managers SA on December 31, 2025, the combined positions of the two entities resulted in the crossing of the 3% threshold.

*

* *

Contact:

Nyxoah

John Landry, CFO



Attachment



EN
12/01/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Y...

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 Strong Start in First Full Quarter of U.S. Commercialization Mont-Saint-Guibert, Belgium – January 12, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment a...

 PRESS RELEASE

Nyxoah Annonce ses Résultats Préliminaires pour le Quatrième Trimestre...

Nyxoah Annonce ses Résultats Préliminaires pour le Quatrième Trimestre et l'Ensemble de l'Exercice 2025 et Communique des Prévisions de Chiffre d'Affaires pour le Premier Trimestre 2026 INFORMATIONS PRIVILÉGIÉESINFORMATIONS RÉGLEMENTÉES Nyxoah Annonce ses Résultats Préliminaires pour le Quatrième Trimestre et l'Ensemble de l'Exercice 2025 et Communique des Prévisions de Chiffre d'Affaires pour le Premier Trimestre 2026 Un Démarrage Solide pour le Premier Trimestre Complet de Commercialisation aux États-Unis Mont-Saint-Guibert, Belgique – 12 janvier 2026, 22h05 CET / 16h05 ET – Nyxoah SA ...

 PRESS RELEASE

Publication relative à une notification de transparence

Publication relative à une notification de transparence INFORMATION RÉGLEMENTÉE Publication relative à une notification de transparence Mont-Saint-Guibert (Belgique), le 12 janvier 2026, 7:00h CET / 1:00h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) annonce qu’elle a reçu une notification de transparence comme détaillée ci-dessous. BNP Paribas Asset Management Le 8 janvier 2026, Nyxoah a reçu une notification de transparence de BNP Paribas Asset Management SA. Sur la base de ...

 PRESS RELEASE

Publication relating to transparency notification

Publication relating to transparency notification REGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), January 12, 2026, 7:00 am CET / 1:00 am ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. BNP Paribas Asset Management On January 8, 2026, Nyxoah received a transparency notification from BNP Paribas Asset Management SA. Based on the notification, BNP Paribas Asset Manag...

 PRESS RELEASE

Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference Mont-Saint-Guibert, Belgium – December 29, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, Jan. 15, 2026. The Company's pre...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch